Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis.
about
Dimethyl fumarate alters B-cell memory and cytokine production in MS patientsB Cell-Directed Therapeutics in Multiple Sclerosis: Rationale and Clinical Evidence.Thymosin-α1 expands deficient IL-10-producing regulatory B cell subsets in relapsing-remitting multiple sclerosis patients.Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis.Deciphering the Role of B Cells in Multiple Sclerosis-Towards Specific Targeting of Pathogenic Function.Role of Immunological Memory Cells as a Therapeutic Target in Multiple Sclerosis.Optimal response to dimethyl fumarate associates in MS with a shift from an inflammatory to a tolerogenic blood cell profile.The NRF2 pathway as potential biomarker for dimethyl fumarate treatment in multiple sclerosis.
P2860
Q33646238-3DE6B305-668C-4F5B-A8B5-AE97EE7985D3Q38795434-BA1D332A-C973-417F-A344-F9F2B9340F04Q38920482-2F711650-199A-4AEC-936B-E03D5694E6A7Q39119839-FB5C9EAA-AD6C-436D-80A7-0E81522CE564Q47102132-5726F5BF-33B0-4AFD-8F30-A203ED3C9785Q47130362-51422625-8C2C-4325-BEE9-043CCD1A28F4Q50577568-7C7E1F62-192C-4C13-9331-5F2AAB8E0BF1Q55439580-D7BEDC80-59F5-4B23-BD62-59E8DE3E8AFB
P2860
Interferon-β therapy specifically reduces pathogenic memory B cells in multiple sclerosis patients by inducing a FAS-mediated apoptosis.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Interferon-β therapy specifica ...... cing a FAS-mediated apoptosis.
@en
type
label
Interferon-β therapy specifica ...... cing a FAS-mediated apoptosis.
@en
prefLabel
Interferon-β therapy specifica ...... cing a FAS-mediated apoptosis.
@en
P2093
P2860
P50
P356
P1476
Interferon-β therapy specifica ...... ucing a FAS-mediated apoptosis
@en
P2093
Elena Giacomini
Eliana Marina Coccia
Marco Salvetti
Martina Severa
P2860
P304
P356
10.1038/ICB.2016.55
P577
2016-06-06T00:00:00Z